Trial Profile
A Pilot Phase Ia, Safety and Immunogenicity Dose Escalation Clinical Trial to Evaluate Vaccine Against Ricin Toxin (RiVax) in Human Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2008
Price :
$35
*
At a glance
- Drugs Ricin vaccine (Primary)
- Indications Ricin poisoning
- Focus Adverse reactions; First in man; Pharmacodynamics
- 13 Feb 2008 New trial record.
- 14 Feb 2006 According to results published in the Proceedings of the National Academy of Sciences of the United States of America, this study was conducted under an investigational new drug application submitted to the Food and Drug Administration.